» Articles » PMID: 26298415

Renal Sympathetic Nerve Denervation Using Intraluminal Ultrasound Within a Cooling Balloon Preserves the Arterial Wall and Reduces Sympathetic Nerve Activity

Overview
Date 2015 Aug 24
PMID 26298415
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Circumferential ablation of renal sympathetic nerves using catheter-based ultrasound energy was studied in a preclinical in vivo model. The aim was to investigate the benefit of cooling the arterial wall and the extent of renal nerve injury based on histopathology, and to correlate the injury with kidney norepinephrine levels.

Methods And Results: Computer simulations of the ultrasound transducer within the cooling balloon demonstrated a circumferentially uniform heating profile. In vivo characterisation was performed in 10 normotensive pigs. Nine were treated bilaterally with ultrasound and survived for seven days (n=8) or were sacrificed acutely (n=1). Acutely, TTC staining of the renal arteries treated with ultrasound energy in the presence of cooling demonstrated viable tissue consistent with preservation of the arterial medial layer. Histological studies demonstrated no endothelial injury and minimal to no injury to the media of the renal arterial wall at seven days. Overall, circumferential nerve damage with up to 76% of nerve bundles affected within 7.5 mm of the arterial lumen was observed. Kidney norepinephrine (NEPI) levels were significantly reduced in all animals compared to a non-treated control animal (n=1) and correlated with the degree of nerve damage. A greater reduction in NEPI and a greater percentage of affected nerves was observed in arteries treated with two or three bilateral ultrasound emissions.

Conclusions: Catheter-based ultrasound delivered within a cooling balloon is effective at targeting the majority of the renal nerves circumferentially, resulting in significantly decreased kidney NEPI levels without damaging the arterial wall in a porcine model.

Citing Articles

Cardiac sympathetic nerve activity trends after renal denervation in heart failure with preserved ejection fraction.

Shiraki T, Mizuno H, Kishi T, Asakura M, Asanoi H, Yasumura Y ESC Heart Fail. 2024; 11(4):2426-2431.

PMID: 38659233 PMC: 11287327. DOI: 10.1002/ehf2.14770.


Renal denervation in the management of hypertension.

Lauder L, Kandzari D, Luscher T, Mahfoud F EuroIntervention. 2024; 20(8):e467-e478.

PMID: 38629418 PMC: 11017226. DOI: 10.4244/EIJ-D-23-00836.


Present Evidence of Determinants to Predict the Efficacy of Renal Denervation.

Zhou H, Xu Y, Chen W, Wang L, Du H, Liu H Int J Hypertens. 2022; 2022:5694127.

PMID: 35992203 PMC: 9391193. DOI: 10.1155/2022/5694127.


Renal denervation in resistant hypertension: a review of clinical trials and future perspectives.

Yamamoto E, Sueta D, Tsujita K Cardiovasc Interv Ther. 2022; 37(3):450-457.

PMID: 35474179 DOI: 10.1007/s12928-022-00854-2.


Renal Denervation by Noninvasive Stereotactic Radiotherapy Induces Persistent Reduction of Sympathetic Activity in a Hypertensive Swine Model.

Cai X, Shen Y, Yang Y, Wang W, Qian L, Cai J J Am Heart Assoc. 2021; 10(16):e020068.

PMID: 34369204 PMC: 8475062. DOI: 10.1161/JAHA.120.020068.